Search results for "pancrea"

showing 10 items of 814 documents

IS CT USEFUL FOR THE DIAGNOSIS OF PANCREATIC FISTULA AFTER PANCREATICODUODENECTOMY IN PATIENTS WITH "SOFT" PANCREAS?

2007

CT pancreas
researchProduct

Effects of cadmium exposure on the ultrastructure of hepatopancreatic cells of Thais haemastoma (gastropoda, prosobranchia)

1993

Abstract Specific histopathological parameters have been proposed as good indicators of heavy-metal pollution. Hence the study of ultrastructural alterations in target organs from sentinel animals after heavy-metal exposure may provide a useful tool in understanding the cellular role in heavy-metal metabolism. The main purpose of this study was the determination of the ultrastructural changes in the different hepatopancreatic-cell types of Thais haemastoma after experimental exposure to cadmium. Specimens of this species from the Gulf of Valencia were exposed to sublethal doses of cadmium during a period of 96 h. The hepatopancreas was excised and prepared in a routine manner for electron m…

CadmiumbiologyEndoplasmic reticulumExtracellular digestionchemistry.chemical_elementGeneral MedicineMetabolismAnatomyAquatic ScienceOceanographybiology.organism_classificationPollutionExcretionBasophilicBiochemistrychemistryUltrastructureHepatopancreasMarine Environmental Research
researchProduct

Isotopic composition of cattle pancreatic stones: biological and geochemical implications.

1977

Latitudinal variations of the O18/O16-ratios of carbonate and phosphate of cattle pancreatic stones parallel a similar pattern of oxygen isotope values in rain water. C13/C12-ratios were virtually identical for the 7 cases studied. Isotopic measurements of mammalian hard tissues may be used for studying short-term climatic variations through Quaternary.

Calcium PhosphatesGeological PhenomenaClimateDenmarkMineralogyCattle DiseasesOxygen IsotopesIsotopes of oxygenCalculiCalcium CarbonateCellular and Molecular Neurosciencechemistry.chemical_compoundAnimalsPancreatic stonesMolecular BiologyFinlandPharmacologyCarbon IsotopesChemistryGeologyCell BiologyPhosphateIsotopic compositionEnglandPancreatitisEnvironmental chemistryMolecular MedicineCarbonateCattleFranceQuaternaryExperientia
researchProduct

Plasma calprotectin assay in patients with acute pancreatitis

2003

CalprotectinSettore MED/09 - Medicina Internaacute pancreatitis
researchProduct

Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3,4]thiadiazol-2-yl)-1H-indole …

2019

Heterocyclic rings are recognized as key components of many natural, semi-synthetic and synthetic molecules with a broad spectrum of biological activities. Among these molecules, the indole and imidazo[2,1-b][1,3,4]thiadiazole systems have recently been described as useful scaffolds for the design of anticancer agents. Herein the antitumor activity of a series of 3-(6-phenylimidazo[2,1-b][1,3,4]thiadiazol-2-yl)-1H-indoles, designed as hybrid structures, was assessed. Seven out of 10 compounds (1a-g) were submitted to National Cancer Institute (NCI). Remarkably, compound 1g showed antiproliferative activity against the full panel of sixty human cancer lines, with half-maximal inhibitory conc…

Cancer Research3Stereochemistry1-b][1Indole systemAntineoplastic Agent03 medical and health sciences0302 clinical medicine4]thiadiazole derivativeCell MovementCell Line TumorPancreatic cancermedicineImidazo[2Cell ProliferationBiological evaluationAntitumor activityIndole testChemistryCancerAnti-migratory activityPancreatic cancerGeneral Medicinemedicine.diseaseIn vitroPancreatic NeoplasmsOncologyIndolePancreatic cancer cell030220 oncology & carcinogenesisAnti-proliferative activityHuman cancerHuman
researchProduct

alpha GalNAc is essential for recognition of Exo-1 epithelial antigen by mouse monoclonal antibody Pa-G-14.

1993

Mouse monoclonal antibody Pa-G-14 detects Exo-1, an antigen whose expression is regulated in the processes of epithelial-cell differentiation and transformation. The epitope recognized by Pa-G-14 is present both in glycosphingolipids and in mucin glycoproteins. To characterize the specificity of Pa-G-14, immuno-thin-layer chromatography, biochemical, and enzymatic treatment of glycosphingolipid extracts from human pancreas were used. The antibody bound to all blood-group-A substances; alpha GalNAc, but not fucose, was essential for reactivity. In ELISA, Pa-G-14 also reacted with ovine and bovine submaxillary mucins but not with porcine submaxillary mucin. Binding to ovine submaxillary mucin…

Cancer ResearchAcetylgalactosaminemedicine.drug_classMolecular Sequence DataSubmandibular GlandMonoclonal antibodyFucoseEpitopeGlycosphingolipidschemistry.chemical_compoundEpitopesMiceAntigenAntibody SpecificityAntigens NeoplasmmedicineAnimalsHumansPancreasGlycoproteinschemistry.chemical_classificationSheepbiologyMucinMucinsOvine Submaxillary MucinAntibodies MonoclonalMolecular biologycarbohydrates (lipids)OncologychemistryBiochemistryCarbohydrate SequenceAntigens Surfacebiology.proteinCattleAntibodyGlycoproteinInternational journal of cancer
researchProduct

Expression of chemokine receptor CXCR4 correlates with progression of pancreatic cancer

2006

14018 Background: Despite many pathophysiological analyses, the process of tumor dissemination of pancreatic cancer remains vague. In diverse other tumor entities, expression of the chemokine receptor CXCR4 has been linked to tumor dissemination and poor prognosis. Therefore, we evaluated, if the expression of this chemokine receptor exerts similar effects in human pancreatic cancer. Methods: Expression of CXCR4 was evaluated in 120 patients with histologically confirmed pancreatic cancer and eight different pancreatic cancer cell lines. Expression intensities of tumor samples were correlated with both, tumor and patients characteristics. Results: Human pancreatic cancer samples and cell l…

Cancer ResearchCCR2Chemokinebiologybusiness.industrymedicine.diseaseCXCR4PathophysiologyChemokine receptorOncologyCXCL5Pancreatic cancerCancer researchbiology.proteinmedicineCA19-9businessJournal of Clinical Oncology
researchProduct

Cyclin dependent kinase-1 (Cdk-1) inhibition as a novel therapeutic strategy against pancreatic ductal adenocarcinoma (pdac)

2021

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in humans, due to late diagnosis and limited treatment possibilities. Improved treatment for PDAC patients is warranted. Cyclin-dependent kinase 1 (CDK1) is a stimulator of cell cycle progression and its activity is regularly enhanced in pancreatic cancer cells. Therefore, CDK1 has been proposed as a novel drug target to treat patients with PDAC. This review describes the potential of CDK1 inhibition as a treatment for PDAC by outlining the molecular pathways influenced by CDK1 inhibition and new therapeutic strategies. Abstract The role of CDK1 in PDAC onset and development is two-fold. Firstly, since …

Cancer ResearchCell cycle checkpointendocrine system diseasesmedicine.medical_treatmentReviewenvironment and public healthTargeted therapyCyclin-dependent kinaseCancer stem cellPancreatic cancermedicineNovel treatmentCDK1 inhibitionRC254-282Cyclin-dependent kinase 1biologyChemistryNeoplasms. Tumors. Oncology. Including cancer and carcinogensPDACPancreatic cancerCell cyclemedicine.diseaseenzymes and coenzymes (carbohydrates)Oncologybiology.proteinCancer researchStem cellbiological phenomena cell phenomena and immunityCell cycle regulation
researchProduct

The DNA damage-induced decrease of Bcl-2 is secondary to the activation of apoptotic effector caspases.

2003

Apoptosis induced by DNA-damaging agents or radiation mainly proceeds through death receptor-independent caspase activation. The release of mitochondrial apoptogenic proteins, such as cytochrome c, into the cytoplasm leading to Apaf1-dependent activation of caspase-9 is a key event in this pathway. The permeability of the mitochondrial outer membrane is regulated by the various pro- and antiapoptotic Bcl-2 family proteins, and it is thought that DNA damage triggers apoptosis through the downregulation of antiapoptotic Bcl-2. Using murine embryonic fibroblasts (MEF) deficient and proficient in Apaf1, we show that DNA-damaging agents and radiation lead to a decline in Bcl-2 protein only in wt…

Cancer ResearchDNA damageCell TransplantationUltraviolet RaysTransplantation HeterologousApoptosisMice SCIDAdenocarcinomamedicine.disease_causeAdenoviridaeAmino Acid Chloromethyl KetonesMiceDownregulation and upregulationGeneticsmedicineTumor Cells CulturedAnimalsHumansAPAF1Enzyme InhibitorsMolecular BiologyCaspaseEtoposidebiologyDose-Response Relationship DrugCytochrome cProteinsDose-Response Relationship RadiationFibroblastsMolecular biologyCaspase InhibitorsCell biologyEnzyme ActivationPancreatic NeoplasmsApoptotic Protease-Activating Factor 1Proto-Oncogene Proteins c-bcl-2ApoptosisCytoplasmCaspasesbiology.proteinDactinomycinCarcinogenesisGene DeletionDNA DamageOncogene
researchProduct

GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer

2021

Pancreatic cancer is an aggressive malignancy with increasing incidence and poor prognosis due to its late diagnosis and intrinsic chemoresistance. Most pancreatic cancer patients present with locally advanced or metastatic disease characterized by inherent resistance to chemotherapy. These features pose a series of therapeutic challenges and new targets are urgently needed. Glycogen synthase kinase 3 beta (GSK3β) is a conserved serine/threonine kinase, which regulates key cellular processes including cell proliferation, DNA repair, cell cycle progression, signaling and metabolic pathways. GSK3β is implicated in non-malignant and malignant diseases including inflammation, neurodegenerative …

Cancer ResearchDNA repairDruggabilityDiseaseMalignancyPancreatic cancerHumansMedicinePharmacology (medical)GSK3BCell ProliferationPharmacologyGlycogen Synthase Kinase 3 betabusiness.industryKinaseGSK3βCancerTumor chromatin profilingOncogenesPancreatic cancermedicine.diseaseAnticancer drug combinationsPancreatic NeoplasmsInfectious DiseasesOncologyDrug Resistance NeoplasmCancer researchbusinessChemoresistanceDrug Resistance Updates
researchProduct